GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mega Genomics Ltd (HKSE:06667) » Definitions » Price-to-Owner-Earnings

Mega Genomics (HKSE:06667) Price-to-Owner-Earnings : 11.88 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Mega Genomics Price-to-Owner-Earnings?

As of today (2024-06-05), Mega Genomics's share price is HK$9.98. Mega Genomics's Owner Earnings per Share (TTM) ended in Dec. 2023 was HK$0.84. It's Price-to-Owner-Earnings for today is 11.88.


The historical rank and industry rank for Mega Genomics's Price-to-Owner-Earnings or its related term are showing as below:

HKSE:06667' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.76   Med: 11.17   Max: 14.38
Current: 11.88

During the past 5 years, the highest Price-to-Owner-Earnings of Mega Genomics was 14.38. The lowest was 9.76. And the median was 11.17.


HKSE:06667's Price-to-Owner-Earnings is ranked better than
83.33% of 66 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.25 vs HKSE:06667: 11.88

As of today (2024-06-05), Mega Genomics's share price is HK$9.98. Mega Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.15. Therefore, Mega Genomics's PE Ratio for today is 65.23.

As of today (2024-06-05), Mega Genomics's share price is HK$9.98. Mega Genomics's EPS without NRI for the trailing twelve months (TTM) ended in was HK$0.08. Therefore, Mega Genomics's PE Ratio without NRI for today is 121.71.

During the past 5 years, Mega Genomics's highest PE Ratio without NRI was 4133.33. The lowest was 13.77. And the median was 2601.67.


Mega Genomics Price-to-Owner-Earnings Historical Data

The historical data trend for Mega Genomics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Genomics Price-to-Owner-Earnings Chart

Mega Genomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - 12.26

Mega Genomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - 12.26

Competitive Comparison of Mega Genomics's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Mega Genomics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Genomics's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Mega Genomics's Price-to-Owner-Earnings falls into.



Mega Genomics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Mega Genomics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=9.98/0.84
=11.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mega Genomics  (HKSE:06667) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Mega Genomics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Mega Genomics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Genomics (HKSE:06667) Business Description

Traded in Other Exchanges
N/A
Address
North Garden Road, 401 Health Work, Haidian District, Beijing, CHN
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.
Executives
Guo Meiling 2101 Beneficial owner
Lin Lin 2101 Beneficial owner
Yu Rong 2501 Other
Infinite Galaxy Health Limited 2101 Beneficial owner
Mei Nian Investment Limited 2101 Beneficial owner
Kastle Limited 2501 Other
Mega Marvelous Limited 2501 Other
Yurong Technology Limited 2101 Beneficial owner
Niu Zhencai 2201 Interest of corporation controlled by you
Mei Nian Da Jian Kang Chan Ye Kong Gu Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing He He Heng Ye Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Shi Ji Yu Neng Ke Ji You Xian Gong Si 2501 Other
Tian Jin Shi Ji Yu Neng Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner

Mega Genomics (HKSE:06667) Headlines

No Headlines